Articles by Fini BioInvestments SA

  • Posted on 6/28/18

    Cara Therapeutics: Scratching An Itch Left Unscratched

    Company Introduction And ThesisCara Therapeutics Inc. (CARA) is a small-cap biopharmaceutical company whose focus revolves around pruritus (severe itch) and pain, specifically through selective targeting and . . .